Vincerx Pharma (VINC) Competitors $0.03 +0.00 (+3.50%) As of 09/5/2025 03:53 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VINC vs. BON, TRVN, MYMD, NCNA, SMFL, SYRS, NAVB, OBSV, SCPS, and VRPXShould you be buying Vincerx Pharma stock or one of its competitors? The main competitors of Vincerx Pharma include Bon Natural Life (BON), Trevena (TRVN), MyMD Pharmaceuticals (MYMD), NuCana (NCNA), Smart for Life (SMFL), Syros Pharmaceuticals (SYRS), Navidea Biopharmaceuticals (NAVB), ObsEva (OBSV), Scopus BioPharma (SCPS), and Virpax Pharmaceuticals (VRPX). These companies are all part of the "pharmaceutical products" industry. Vincerx Pharma vs. Its Competitors Bon Natural Life Trevena MyMD Pharmaceuticals NuCana Smart for Life Syros Pharmaceuticals Navidea Biopharmaceuticals ObsEva Scopus BioPharma Virpax Pharmaceuticals Vincerx Pharma (NASDAQ:VINC) and Bon Natural Life (NASDAQ:BON) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation. Do analysts recommend VINC or BON? Vincerx Pharma currently has a consensus price target of $40.00, suggesting a potential upside of 122,976.92%. Given Vincerx Pharma's stronger consensus rating and higher possible upside, analysts clearly believe Vincerx Pharma is more favorable than Bon Natural Life.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vincerx Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Bon Natural Life 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, VINC or BON? Vincerx Pharma has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500. Comparatively, Bon Natural Life has a beta of -0.46, meaning that its share price is 146% less volatile than the S&P 500. Which has preferable earnings & valuation, VINC or BON? Bon Natural Life has higher revenue and earnings than Vincerx Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVincerx PharmaN/AN/A-$40.16M-$20.600.00Bon Natural Life$23.84M0.01$400KN/AN/A Do institutionals & insiders hold more shares of VINC or BON? 44.0% of Vincerx Pharma shares are owned by institutional investors. Comparatively, 0.6% of Bon Natural Life shares are owned by institutional investors. 15.6% of Vincerx Pharma shares are owned by company insiders. Comparatively, 26.5% of Bon Natural Life shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media favor VINC or BON? In the previous week, Vincerx Pharma and Vincerx Pharma both had 1 articles in the media. Bon Natural Life's average media sentiment score of 1.00 beat Vincerx Pharma's score of -1.00 indicating that Bon Natural Life is being referred to more favorably in the news media. Company Overall Sentiment Vincerx Pharma Negative Bon Natural Life Positive Is VINC or BON more profitable? Bon Natural Life's return on equity of 0.00% beat Vincerx Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Vincerx PharmaN/A -248.33% -132.73% Bon Natural Life N/A N/A N/A SummaryBon Natural Life beats Vincerx Pharma on 6 of the 11 factors compared between the two stocks. Get Vincerx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VINC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VINC vs. The Competition Export to ExcelMetricVincerx PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$170K$832.52M$5.82B$9.94BDividend YieldN/A4.84%6.70%4.53%P/E Ratio0.001.1676.2126.11Price / SalesN/A26.54557.45121.74Price / CashN/A19.5625.7029.11Price / Book0.006.7311.486.09Net Income-$40.16M-$3.82M$3.29B$266.19M7 Day PerformanceN/A0.54%1.28%0.45%1 Month PerformanceN/A12.76%8.56%5.05%1 Year PerformanceN/A30.05%61.19%26.04% Vincerx Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VINCVincerx Pharma2.4938 of 5 stars$0.03+3.5%$40.00+122,976.9%-99.8%$170KN/A0.0060Negative NewsShort Interest ↑Gap UpBONBon Natural Life1.2536 of 5 stars$1.41-0.5%N/AN/A$240K$23.84M0.00100Short Interest ↓TRVNTrevena1.4446 of 5 stars$0.25+20,733.3%$5.00+1,900.0%N/A$240K$443K-0.0140Gap UpHigh Trading VolumeMYMDMyMD PharmaceuticalsN/A$0.05-21.6%N/AN/A$114KN/A0.006Gap DownHigh Trading VolumeNCNANuCana0.7564 of 5 stars$3.19-0.3%$5,000.00+156,639.8%-99.5%$100KN/A0.0030News CoveragePositive NewsShort Interest ↑SMFLSmart for LifeN/A$0.01+636.4%N/A-99.7%$57K$11.11M0.00110Gap UpSYRSSyros Pharmaceuticals3.9686 of 5 stars$0.00+25.0%$1.00+49,900.0%-99.9%$54K$386K0.00120NAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-50.0%$50K$8.13K0.0010OBSVObsEvaN/A$0.00+400.0%N/AN/A$39KN/A0.0050SCPSScopus BioPharmaN/A$0.00+33.3%N/AN/A$17KN/A0.009VRPXVirpax Pharmaceuticals0.1024 of 5 stars$0.01flatN/A-99.9%$14KN/A0.007 Related Companies and Tools Related Companies BON Competitors TRVN Competitors MYMD Competitors NCNA Competitors SMFL Competitors SYRS Competitors NAVB Competitors OBSV Competitors SCPS Competitors VRPX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VINC) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VINC Stock Alerts